Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy.
Li Y, Yang C, Liu Z, Du S, Can S, Zhang H, Zhang L, Huang X, Xiao Z, Li X, Fang J, Qin W, Sun C, Wang C, Chen J, Chen H.
Li Y, et al. Among authors: li x.
Mol Cancer. 2022 Jan 2;21(1):2. doi: 10.1186/s12943-021-01462-z.
Mol Cancer. 2022.
PMID: 34980132
Free PMC article.